Author:
Fiorentini Giammaria,Aliberti Camillo,Coschiera Paolo,Casadei Virginia,Mulazzani Luca,Baldelli Anna Maria,Mambrini Andrea,Rossi David
Publisher
Springer Berlin Heidelberg
Reference31 articles.
1. Giordano SH: Update on locally advanced breast cancer. Oncologist; 2003; 8(6): 521–30.
2. Specht J, Gralow JR: Neoadjuvant chemotherapy for locally advanced breast cancer. Semin Radiat Oncol. 19(4):222–8,2009.
3. Bergh J, Jönsson PE, Glimelius B, Nygren P: A systematic overview of chemotherapy effects in breast cancer. Acta Oncol 40(2–3):253–812001.
4. Carrick S, Parker S, Thornton CE, Ghersi D, Simes J, Wilcken N: Single agent versus combination chemotherapy for metastatic breast cancer. Cochrane Database Syst Rev. 15;(2):CD003372, 2009.
5. Heidemann E, Stoeger H, Souchon R, Hirschmann WD, Bodenstein H, Oberhoff C, Fischer JT, Schulze M, Clemens M, Andreesen R, Mahlke M, König M, Scharl A, Fehnle K, Kaufmann M: Is first-line single-agent mitoxantrone in the treatment of high-risk metastatic breast cancer patients as effective as combination chemotherapy? No difference in survival but higher quality of life were found in a multicenter randomized trial. Ann Oncol. 2002 Nov; 13(11):1717–29.